Time trends in chemotherapy (administration and costs) and relative survival in stage III colon cancer patients-a large population-based study from 1990 to 2008

Acta Oncologica

Volumn 52, Issue 5, 2013, Pages 941-949

  Van Den Broek, Colette B M ^a   Bastiaannet, Esther ^a   Dekker, Jan Willem T ^a   Portielje, Johanneke E A ^b   De Craen, Anton J M ^a   Elferink, Marloes A G ^c   Van De Velde, Cornelis J H ^a   Liefers, Gerrit Jan ^a   Kapiteijn, Ellen ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HAGA HOSPITAL   (Netherlands)

^c Section of Epidemiology   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CHILD; COLON ADENOCARCINOMA; DRUG COST; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; POPULATION RESEARCH; PRIORITY JOURNAL; SCHOOL CHILD; ADJUVANT CHEMOTHERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; COLON CANCER; OVERALL SURVIVAL; REVIEW; VERY ELDERLY;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CHILD; COHORT STUDIES; COLON; COLONIC NEOPLASMS; DRUG COSTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NETHERLANDS; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 84877344883     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2012.739730     Document Type: Article

References (25)

1. [cited 2012 Feb 3]. Available from: http://www.cijfersover kanker.nl/(Website from The Netherlands Cancer Registry with detailed information about the incidence, prevalence, survival, and mortality of cancers in The Netherlands).
2. Benson AB , S chrag D , S omerfi eld M R , C ohen AM , Figueredo AT , Flynn PJ , et al American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer . J Clin Oncol 2004; 22: 3408-19 .
3. Moertel CG , F leming TR , M acdonald JS , H aller D G , Laurie JA , Goodman PJ , et al . Levamisole and fl uorouracil for adjuvant therapy of resected colon carcinoma . N Engl J Med 1990; 322: 352-8 .
4. QUASAR Collaborative Group. C omparison of fl ourouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial . Lancet 2000; 355: 1588-96 .
5. O'Connell M J , M ailliard J A , K ahn M J , M acdonald JS , Haller DG , Mayer RJ , et al . Controlled trial of fl uorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer . J Clin Oncol 1997; 15: 246-50 .
6. Andre T , B oni C , M ounedji-Boudiaf L , N avarro M , Tabernero J , Hickish T , et al . Oxaliplatin, fl uorouracil, and leucovorin as adjuvant treatment for colon cancer . N Engl J Med 2004; 350: 2343-51 . Cassidy J , Saltz L
7. , T welves C , V an Cutsem E ., H off P , Kang Y , et al . Effi cacy of capecitabine versus 5-fl uorouracil in colorectal and gastric cancers: A meta-analysis of individual data from 6171 patients . Ann Oncol 2011; 22: 2604-9 .
8. [cited 2012 Feb 3]. Available from: http://www.oncoline.nl/(Website with the guidelines about cancer treatment in The Netherlands).
9. Papamichael D , A udisio R , H oriot JC, G limelius B, S astre J, Mitry E , et al . Treatment of the elderly colorectal cancer patient: SIOG expert recommendations . Ann Oncol 2009; 20: 5-16 .
10. Sargent D J , G oldberg R M , J acobson S D , M acdonald JS , Labianca R , Haller DG , et al . A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients . N Engl J Med 2001; 345: 1091-7 .
11. Schouten LJ, H oppener P , v an den Brandt P A , K nottnerus JA , Jager JJ . Completeness of cancer registration in Limburg, The Netherlands . Int J Epidemiol 1993; 22: 369-76 .
12. Brenner H , H akulinen T . U p-to-date long-term survival curves of patients with cancer by period analysis . J Clin Oncol 2002; 20: 826-32 .
13. Brenner H , B ouvier AM , F oschi R , H ackl M , L arsen I K , Lemmens V , et al . Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: The EUROCARE study. Int J Cancer 2012; 131:1649-58.
14. van Steenbergen LN , L emmens VE , R utten HJ, Wymenga AN , Nortier JW , Janssen-Heijnen ML . Increased adjuvant treatment and improved survival in elderly stage III colon cancer patients in The Netherlands . Ann Oncol 2012; 131: 1649-58 .
15. Lemmens V E , v an Halteren AH , J anssen-Heijnen M L , Vreugdenhil G , Repelaer van Driel OJ , Coebergh JW . Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity . Ann Oncol 2005; 16: 767-72 .
16. van Steenbergen LN , E lferink MA , K rijnen P , L emmens VE , Siesling S , Rutten HJ , et al . Improved survival of colon cancer due to improved treatment and detection: A nationwide population-based study in The Netherlands 1989-2006 . Ann Oncol 2010; 21: 2206-12 .
17. Droz JP , A apro M , B alducci L . O vercoming challenges associated with chemotherapy treatment in the senior adult population . Crit Rev Oncol Hematol 2008; 68(Suppl 1): S1-8 .
18. Yellen SB , C ella DF , L eslie WT . A ge and clinical decision making in oncology patients . J Natl Cancer Inst 1994; 86: 1766-70 .
19. Kuebler JP , W ieand HS , O 'Connell MJ , S mith RE , Colangelo LH , Yothers G , et al . Oxaliplatin combined with weekly bolus fl uorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: Results from NSABP C-07 . J Clin Oncol 2007; 25: 2198-204 .
20. Andre T , B oni C , N avarro M , T abernero J , H ickish T , Topham C , et al . Improved overall survival with oxaliplatin, fl uorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial . J Clin Oncol 2009; 27: 3109-16 .
21. Yothers G , O 'Connell MJ , A llegra CJ, K uebler JP , Colangelo LH , Petrelli NJ , et al . Oxaliplatin as adjuvant therapy for colon cancer: Updated results of NSABP C-07 trial, including survival and subset analyses . J Clin Oncol 2011; 29: 3768-74 .
22. Pandor A , E ggington S , P aisley S , T appenden P , S utcliffe P . The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: Systematic review and economic evaluation . Health Technol Assess 2006; 10: iii-xiv ,1.
23. Bastiaannet E, S ampieri K, D ekkers OM , De Craen AJ , van Herk-Sukel MP , Lemmens V , et al . Use of aspirin postdiagnosis improves survival for colon cancer patients . Br J Cancer 2012; 106: 1564-70 .
24. Derwinger K , C arlsson G , G ustavsson B . S tage migration in colorectal cancer related to improved lymph node assessment . Eur J Surg Oncol 2007; 33: 849-53 .
25. Colorectal Cancer Collaborative Group. S urgery for colorectal cancer in elderly patients: A systematic review . Lancet 2000; 356: 968-74 .